Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling - Nature

Clicks: 191
ID: 272033
1970
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #206 of 375 articles by views in Nature

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 375 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically heterogeneous: 40% of patients respond well to current therapy and have prolonged survival, whereas the remainder succumb to the disease. We proposed that this variability in natural history reflects unrecognized molecular heterogeneity in the tumours. Using DNA microarrays, we have conducted a systematic characterization of gene expression in B-cell malignancies. Here we show that there is diversity in gene expression among the tumours of DLBCL patients, apparently reflecting the variation in tumour proliferation rate, host response and differentiation state of the tumour. We identified two molecularly distinct forms of DLBCL which had gene expression patterns indicative of different stages of B-cell differentiation. One type expressed genes characteristic of germinal centre B cells (‘germinal centre B-like DLBCL’); the second type expressed genes normally induced during in vitro activation of peripheral blood B cells (‘activated B-like DLBCL’). Patients with germinal centre B-like DLBCL had a significantly better overall survival than those with activated B-like DLBCL. The molecular classification of tumours on the basis of gene expression can thus identify previously undetected and clinically significant subtypes of cancer.
Reference Key
a.1970naturedistinct Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Alizadeh, Ash A.;Eisen, Michael B.;Davis, R. Eric;Ma, Chi;Lossos, Izidore S.;Rosenwald, Andreas;Boldrick, Jennifer C.;Sabet, Hajeer;Tran, Truc;Yu, Xin;Powell, John I.;Yang, Liming;Marti, Gerald E.;Moore, Troy;Hudson, James;Lu, Lisheng;Lewis, David B.;Tibshirani, Robert;Sherlock, Gavin;Chan, Wing C.;Greiner, Timothy C.;Weisenburger, Dennis D.;Armitage, James O.;Warnke, Roger;Levy, Ronald;Wilson, Wyndham;Grever, Michael R.;Byrd, John C.;Botstein, David;Brown, Patrick O.;Staudt, Louis M.;Alizadeh, Ash A.;Eisen, Michael B.;Davis, R. Eric;Ma, Chi;Lossos, Izidore S.;Rosenwald, Andreas;Boldrick, Jennifer C.;Sabet, Hajeer;Tran, Truc;Yu, Xin;Powell, John I.;Yang, Liming;Marti, Gerald E.;Moore, Troy;Hudson, James;Lu, Lisheng;Lewis, David B.;Tibshirani, Robert;Sherlock, Gavin;Chan, Wing C.;Greiner, Timothy C.;Weisenburger, Dennis D.;Armitage, James O.;Warnke, Roger;Levy, Ronald;Wilson, Wyndham;Grever, Michael R.;Byrd, John C.;Botstein, David;Brown, Patrick O.;Staudt, Louis M.;
Journal Nature
Year 1970
DOI
doi:10.1038/35000501
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.